Leukemia

Showing 1 - 25 of 1,387

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pediatric Cancer, Hodgkin Disease, CD30-Positive DLBCL Trial in Milwaukee (anti-CD30 Bispecific Antibody-armed

Not yet recruiting
  • Pediatric Cancer
  • +11 more
  • anti-CD30 Bispecific Antibody-armed anti-CD3-Activated Autologous T-cells (CD30 biAb-AATC)
  • Milwaukee, Wisconsin
    Children's Wisconsin
Sep 14, 2022

Leukemia Trial in Houston (Pirtobrutinib, Obinutuzumab, Venetoclax)

Not yet recruiting
  • Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Sep 7, 2022

Acute Lymphoblastic Leukemia, Leukemia Trial in Houston (Ponatinib, Venetoclax, Mini-hyper CVD)

Recruiting
  • Acute Lymphoblastic Leukemia
  • Leukemia
  • Houston, Texas
    MD Anderson Cancer Center
Aug 23, 2022

Validating Pain Scales in Children and Young Adults

Recruiting
  • Sickle Cell Disease
  • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 24, 2022

    Agricultural Health Study Cohort Pesticide Exposure Study

    Completed
    • Multiple Myeloma
    • +3 more
      • Iowa City, Iowa
      • +1 more
      Aug 18, 2022

      Cognitive Aftereffects of Neurotoxicity in Children and Young

      Not yet recruiting
      • Lymphoma
      • Leukemia
        • Los Angeles, California
        • +2 more
        Aug 17, 2022

        Solid Tumor Malignancy, Hematologic Malignancy, Leukemia Trial run by the NCI (mrna 1273 injection)

        Recruiting
        • Solid Tumor Malignancy
        • +4 more
        • mrna 1273 injection
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Aug 12, 2022

        Lymphoma, Leukemia, Plasma Cell Dyscrasia Trial in San Francisco (Web Application)

        Not yet recruiting
        • Lymphoma
        • +2 more
        • Web Application
        • San Francisco, California
          University of California, San Francisco
        Aug 9, 2022

        Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma AJCC v8, Clinical Stage IB Cutaneous Melanoma

        Recruiting
        • Clinical Stage I Cutaneous Melanoma AJCC v8
        • +33 more
        • Informational Intervention
        • +4 more
        • Los Angeles, California
        • +4 more
        Jul 29, 2022

        Leukemia Trial in Shenyang (IM19 CAR-T cells)

        Recruiting
        • Leukemia
        • IM19 CAR-T cells
        • Shenyang, Liaoning, China
          First Hospital of China Medical University
        Jul 27, 2022

        Leukemia, Lymphoblastic, Leukemia Trial in Houston (CB-103, Venetoclax)

        Not yet recruiting
        • Leukemia, Lymphoblastic
        • Leukemia
        • Houston, Texas
          MD Anderson Cancer Center
        Jul 19, 2022

        Lymphoma, Leukemia Trial in Australia, China (Zanubrutinib, Tislelizumab)

        Completed
        • Lymphoma
        • Leukemia
        • Darlinghurst, New South Wales, Australia
        • +9 more
        Mar 16, 2022

        Verification in Pediatric Chronic GvHD: ABLE 2.0 / PTCTC GVH

        Recruiting
        • Chronic Graft-versus-Host-Disease
        • +4 more
          • San Francisco, California
          • +15 more
          Jun 17, 2022

          Validation for Early Cancer Detection and Minimal Residual

          Recruiting
          • Brain Cancer
          • +19 more
            • Duarte, California
            • +2 more
            Jun 16, 2022

            Improving Communication and BuildingStronger Medical Home Among

            Recruiting
            • Leukemia
            • Non Hodgkin Lymphoma
            • Interview
            • Aurora, Colorado
              Children's Hospital Colorado
            Jun 15, 2022

            NHL, Leukemia Trial in Australia (ETH-155008)

            Recruiting
            • NHL
            • Leukemia
            • Adelaide, South Australia, Australia
            • +4 more
            Jun 8, 2022

            Marathon of Hope Cancer Centres Network Study for Ontario

            Recruiting
            • Breast Cancer
            • +11 more
              • Toronto, Ontario, Canada
                Princess Margaret Cancer Centre
              Jun 6, 2022

              SARS-CoV2 Infection, SARS-CoV-2 Acute Respiratory Disease, Myeloma Trial in London (BMS-986414, BMS-986413)

              Withdrawn
              • SARS-CoV2 Infection
              • +6 more
              • BMS-986414
              • BMS-986413
              • London, United Kingdom
                Imperial College Heathcare NHS Trust
              May 24, 2022

              Leukemia, Leukemia, Myeloid, Monocytic Leukemia Trial in Palo Alto (Enasidenib mesylat dose escalation)

              Recruiting
              • Leukemia
              • +2 more
              • Enasidenib mesylat dose escalation
              • Palo Alto, California
                Stanford Cancer Institute
              May 12, 2022

              iPSC Neurons From Adult Survivors of Childhood Cancer Who Have

              Active, not recruiting
              • Leukemia
              • Lymphoma
                • Memphis, Tennessee
                  St. Jude Children's Research Hospital
                May 16, 2022

                Leukemia Trial (Donor Enriched Activated Natural Killer Cell Infusion)

                Not yet recruiting
                • Leukemia
                • Donor Enriched Activated Natural Killer Cell Infusion
                • (no location specified)
                May 10, 2022

                Solid Tumor, Leukemia, Lymphoma Trial in Cincinnati, Dayton, Oklahoma City (IMPACT, ESO)

                Completed
                • Solid Tumor
                • +3 more
                • IMPACT
                • ESO
                • Cincinnati, Ohio
                • +2 more
                Apr 5, 2022

                Lymphoma, Lymphoma, B-Cell, Leukemia Trial in Houston (Digital Health Coaching)

                Recruiting
                • Lymphoma
                • +6 more
                • Digital Health Coaching
                • Houston, Texas
                  The University of Texas MD Anderson Cancer Center
                Apr 12, 2022